MA32622B1 - Derives de carbonate de quinuclidine et composition medicinale les comprenant - Google Patents

Derives de carbonate de quinuclidine et composition medicinale les comprenant

Info

Publication number
MA32622B1
MA32622B1 MA33683A MA33683A MA32622B1 MA 32622 B1 MA32622 B1 MA 32622B1 MA 33683 A MA33683 A MA 33683A MA 33683 A MA33683 A MA 33683A MA 32622 B1 MA32622 B1 MA 32622B1
Authority
MA
Morocco
Prior art keywords
same
medicinal composition
carbonate derivatives
quinuclidine
quinuclidine carbonate
Prior art date
Application number
MA33683A
Other languages
Arabic (ar)
English (en)
Inventor
Gabriele Amari
Maurizio Delcanale
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA32622B1 publication Critical patent/MA32622B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention porte sur des dérivés de carbonate de quinuclidine agissant en tant qu'antagonistes des récepteurs muscariniques, sur des procédés de préparation de tels dérivés, sur des compositions les comprenant et sur leur utilisation thérapeutique.
MA33683A 2008-08-08 2011-03-08 Derives de carbonate de quinuclidine et composition medicinale les comprenant MA32622B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08162066A EP2154136A1 (fr) 2008-08-08 2008-08-08 Dérivés de carbone de quinuclidine et ses compositions médicales
PCT/EP2009/005272 WO2010015324A1 (fr) 2008-08-08 2009-07-21 Dérivés de carbonate de quinuclidine et composition médicinale les comprenant

Publications (1)

Publication Number Publication Date
MA32622B1 true MA32622B1 (fr) 2011-09-01

Family

ID=40228074

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33683A MA32622B1 (fr) 2008-08-08 2011-03-08 Derives de carbonate de quinuclidine et composition medicinale les comprenant

Country Status (31)

Country Link
US (3) US8039483B2 (fr)
EP (2) EP2154136A1 (fr)
JP (1) JP2011530489A (fr)
KR (1) KR20110044221A (fr)
CN (1) CN102112474B (fr)
AR (1) AR072994A1 (fr)
AT (1) ATE551341T1 (fr)
AU (1) AU2009278306B2 (fr)
CA (1) CA2733380A1 (fr)
CO (1) CO6351790A2 (fr)
CY (1) CY1112724T1 (fr)
DK (1) DK2313404T3 (fr)
EA (1) EA019166B1 (fr)
ES (1) ES2384914T3 (fr)
GE (1) GEP20135744B (fr)
HR (1) HRP20120394T1 (fr)
IL (1) IL211103A (fr)
JO (1) JO2831B1 (fr)
MA (1) MA32622B1 (fr)
ME (1) ME01283A (fr)
MX (1) MX2011001504A (fr)
MY (1) MY156332A (fr)
NZ (1) NZ590987A (fr)
PL (1) PL2313404T3 (fr)
PT (1) PT2313404E (fr)
RS (1) RS52370B (fr)
SI (1) SI2313404T1 (fr)
TW (1) TWI455938B (fr)
UA (1) UA102857C2 (fr)
WO (1) WO2010015324A1 (fr)
ZA (1) ZA201100963B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2230934T3 (da) 2007-12-14 2012-11-26 Aerodesigns Inc Afgivelse af aerosoliserbare næringsmiddelprodukter
EP2154136A1 (fr) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Dérivés de carbone de quinuclidine et ses compositions médicales
EP2206712A1 (fr) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. Dérivés d'amino-ester d'alcaloïde et sa composition médicale
DK2560611T3 (en) 2010-04-21 2018-02-26 Chiesi Farm Spa Process for providing particles with reduced electrostatic charges
RU2569846C2 (ru) 2010-06-22 2015-11-27 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Алкалоидные производные сложных аминоэфиров и включающие их лекарственные композиции
CA2803459A1 (fr) 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Derives aminoester d'alcaloides et compositions medicinales les comprenant
KR20130087406A (ko) 2010-06-22 2013-08-06 키에시 파르마슈티시 엣스. 피. 에이. 알칼로이드 아미노에스테르 유도체 및 이의 의약 조성물
EP2621494B1 (fr) * 2010-09-30 2018-11-07 Chiesi Farmaceutici S.p.A. Utilisation de stéarate de magnésium dans des préparations en poudre sèche destinées à être inhalées
CA2815035A1 (fr) * 2010-10-20 2012-04-26 Chiesi Farmaceutici S.P.A. Derives carbonates destines au traitement de la toux
WO2012069275A1 (fr) 2010-11-26 2012-05-31 Chiesi Farmaceutici S.P.A. Dérivés de glycine et leur utilisation en tant qu'antagonistes des récepteurs muscariniques
MY173998A (en) * 2011-03-18 2020-03-03 Genzyme Corp Glucosylceramide synthase inhibitors
KR20140019409A (ko) 2011-04-29 2014-02-14 키에시 파르마슈티시 엣스. 피. 에이. 알칼로이드 에스텔 및 카바메이트 유도체와 그들의 의약조성물
RU2628082C2 (ru) 2011-12-30 2017-08-14 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Хинуклидиновые эфиры 1-азагетероциклилуксусной кислоты в качестве антимускариновых средств, способ их получения и их лекарственные композиции
JOP20130273B1 (ar) 2012-09-11 2021-08-17 Genzyme Corp مثبطات انزيم (سينثاز) غلوكوسيل سيراميد
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
PT3920912T (pt) 2019-02-04 2025-09-09 Genzyme Corp Tratamento de ciliopatias usando inibidores da glucosilceramida sintase (gcs)
EP4100009A1 (fr) 2020-02-03 2022-12-14 Genzyme Corporation Méthodes de traitement de symptômes neurologiques associés à des maladies lysosomales
CA3186766A1 (fr) 2020-07-24 2022-01-27 Danielle Combessis Compositions pharmaceutiques comprenant du venglustat

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
NZ526580A (en) 2000-12-22 2005-04-29 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as M3 antagonists
EP1383730A2 (fr) * 2001-04-03 2004-01-28 Aryx Therapeutics Composes anticholinergiques et procedes d'utilisation
RS52522B (sr) 2001-12-20 2013-04-30 Chiesi Farmaceutici S.P.A. Derivati 1-alkil-1-azoniabiciklo/2.2.2./oktan karbamata i njihova upotreba kao antagonista muskarinskih receptora
EP1882691A1 (fr) 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Dérivés de quinuclidine comme antagonistes M3
EP2154136A1 (fr) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Dérivés de carbone de quinuclidine et ses compositions médicales
EP2206712A1 (fr) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. Dérivés d'amino-ester d'alcaloïde et sa composition médicale
BR112012032330A2 (pt) 2010-06-22 2016-11-08 Chiesi Farma Spa formulação em pó seco inalável, uso de uma formulação em pó seco, inalador de pó seco e embalagem
CA2815035A1 (fr) 2010-10-20 2012-04-26 Chiesi Farmaceutici S.P.A. Derives carbonates destines au traitement de la toux
US20120220557A1 (en) 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
KR20140019409A (ko) 2011-04-29 2014-02-14 키에시 파르마슈티시 엣스. 피. 에이. 알칼로이드 에스텔 및 카바메이트 유도체와 그들의 의약조성물

Also Published As

Publication number Publication date
NZ590987A (en) 2012-11-30
UA102857C2 (en) 2013-08-27
EP2313404B1 (fr) 2012-03-28
CO6351790A2 (es) 2011-12-20
IL211103A (en) 2014-04-30
ATE551341T1 (de) 2012-04-15
US20100035922A1 (en) 2010-02-11
US20110319444A1 (en) 2011-12-29
MY156332A (en) 2016-02-15
US20120004258A1 (en) 2012-01-05
SI2313404T1 (sl) 2012-07-31
HK1156032A1 (en) 2012-06-01
EP2154136A1 (fr) 2010-02-17
CA2733380A1 (fr) 2010-02-11
WO2010015324A1 (fr) 2010-02-11
EA019166B1 (ru) 2014-01-30
US8039483B2 (en) 2011-10-18
HRP20120394T1 (hr) 2012-06-30
AR072994A1 (es) 2010-10-06
IL211103A0 (en) 2011-04-28
PT2313404E (pt) 2012-07-02
ZA201100963B (en) 2012-05-30
JP2011530489A (ja) 2011-12-22
TW201011022A (en) 2010-03-16
PL2313404T3 (pl) 2012-09-28
AU2009278306B2 (en) 2014-06-26
MX2011001504A (es) 2011-03-29
CN102112474A (zh) 2011-06-29
EP2313404A1 (fr) 2011-04-27
DK2313404T3 (da) 2012-06-04
AU2009278306A1 (en) 2010-02-11
ES2384914T3 (es) 2012-07-13
GEP20135744B (en) 2013-02-11
EA201100161A1 (ru) 2011-10-31
JO2831B1 (en) 2014-09-15
TWI455938B (zh) 2014-10-11
US8404712B2 (en) 2013-03-26
CY1112724T1 (el) 2016-02-10
KR20110044221A (ko) 2011-04-28
CN102112474B (zh) 2014-01-29
ME01283A (fr) 2013-06-20
US8440690B2 (en) 2013-05-14
RS52370B (sr) 2012-12-31

Similar Documents

Publication Publication Date Title
MA32622B1 (fr) Derives de carbonate de quinuclidine et composition medicinale les comprenant
EA201190017A1 (ru) Аминоэфирные производные алкалоидов и их медицинские композиции
CY1123365T1 (el) Ενωσεις που εχουν δραστικοτητα ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα2 αδρενεργικου υποδοχεα
CY1116328T1 (el) Παραγωγα 4 - αμινοπυριμιδινης και η χρηση τους ως ανταγωνιστων α2α υποδοχεων αδενοσινης
CL2012003604A1 (es) Compuestos heterociclicos derivados de piridina carboxamida sustituida; proceso de preparacion; composicion farmaceutica; combinacion farmaceutica; uso en el tratamiento de trastornos proliferativos celulares, enfermedad de parkinson, cancer, entre otros.
MY163055A (en) Polycyclic antagonists of lysophosphatidic acid receptors
IN2012DN02177A (fr)
IN2012DN02730A (fr)
IN2012DN00754A (fr)
ME01532B (me) Jedinjenja
MX2013001677A (es) Formulaciones estables de linaclotida.
BR112012027743A2 (pt) ciclopropil dicarboxamidas e análogos exibindo atividades anticâncer e antiproliferativas
EA201100691A1 (ru) Антагонисты рецепторов лизофосфатидной кислоты
DOP2010000234A (es) Antagonistas n,n-disustituidos de aminoalquilbifenilo de receptores d2 de prostaglandina
CO6620050A2 (es) Derivados de aminopirimidina como moduladores de la lrrk2
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
EA201190142A1 (ru) Производные пиразола, используемые в качестве антагонистов рецептора ccr4
EA201290394A1 (ru) Морфолинотиазолы в качестве позитивных аллостерических модуляторов альфа 7
MY167575A (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
MX381967B (es) Compuestos de 2,3-dihidrobenzofuran-5-ilo como inhibidores de quinasas dyrk.
MX2014000964A (es) Derivados aza heterociclicos sustituidos.
MX347105B (es) Composiciones farmaceuticas que comprenden hidromorfona y naloxona.
EA201501163A1 (ru) Модуляторы рецептора cxcr7
PH12012502300A1 (en) Nicotinic receptor non-competitive antagonists